Why Astra Zeneca sue Mylan for a “blood thinning agent”
Brilinta is a blood thinner used in the treatment of coronary heart disease, angina pectoris which is commonly called as heart attack. Brilinta prevents the blood clots and maintains the blood flow in the body to help reduce the risk of another cardiovascular event. AstraZeneca is a London-based pharmaceutical company, who owns five patents [...]





